Arcadia Investment Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,351
Closed -$35.2K 339
2023
Q3
$35.2K Buy
2,351
+595
+34% +$12.4K 0.01% 233
2023
Q2
$57.1K Sell
1,756
-1,812
-51% -$66.2K 0.01% 213
2023
Q1
$140K Sell
3,568
-183
-5% -$8.95K 0.03% 155
2022
Q4
$198K Buy
+3,751
New +$183K 0.05% 131

Other funds holding SILK

Arcadia Investment Management's SILK Position: Q4 2023 in Review

Arcadia Investment Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 2,351 shares — an estimated $35.2K sold.

Arcadia Investment Management first reported a position in SILK in Q4 2022 and held it in 4 quarters. The position peaked at $198K in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Arcadia Investment Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Arcadia Investment Management sold 2,351 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $35.2K.
  • Arcadia Investment Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • Arcadia Investment Management's Silk Road Medical, Inc. Common Stock position peaked at $198K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Arcadia Investment Management's 13F filing for Q4 2023, filed 7 Feb 2024.